Binary classification experiments on full sentences (negative or somewhat negative vs somewhat positive or positive with neutral sentences discarded) refer to the dataset as SST-2 or SST …

Soluble suppression of tumorigenicity-2 (sST2) is a biomarker widely investigated during the last few years. Its role has become clear in pathological conditions such as fibrosis and inflammation.

Oct 21, 2019 · sST2 is released in response to vascular congestion and inflammatory and profibrotic stimuli, and is a strong, independent predictor of mortality and HF hospitalization in …

Feb 1, 2020 · Soluble suppression of tumorigenicity-2 (sST2) is a biomarker widely investigated during the last few years. Its role has become clear in pathological conditions such as fibrosis …

Soluble suppression of tumorigenesis-2 (sST2) is released in response to vascular congestion and inflammatory and pro-fibrotic stimuli, and is a strong, independent predictor of mortality …

A higher sST2 concentration (upper reference limit of 35 ng/ml) provides a substantial predictive risk of cardiovascular events, such as progressive LV failure, hospitalization for HF, and death .

ST2 (suppression of tumorigenicity 2) protein has gained interest as a potential biomarker in cardiovascular disease. It is known that the IL-33/ST2L system belongs to the cardioprotective …

Oct 29, 2019 · Soluble suppression of tumorigenesis-2 (sST2) is released in response to vascular congestion and inflammatory and pro-fibrotic stimuli, and is a strong, independent predictor of …

ST2 has two main isoforms, ST2L and soluble isoform of ST2 (sST2), by alternative splicing. The interaction between interleukin (IL)-33 and the transmembrane isoform ST2L is up-regulated in …

Mar 30, 2015 · In this review, the role of sST2 as a HF biomarker will be discussed, specifically addressing analytical considerations of measuring sST2 as well as the clinical applications of …